Myocardial ischemia induced by sudden mental stress is associated with bad prognosis, especially in patients with a history of acute myocardial infarction according to this new study. This study, called MIMS-2, was meant to be presented at ACC 2020 together with the World Congress of Cardiology in Chicago, which was shut down because of the<a href="https://solaci.org/en/2020/03/25/virtual-acc-2020-myocardial-ischemia-induced-by-sudden-mental-stress/" title="Read more" >...</a>
This retrospective study has shown a reduction in hospitalization for cardiac failure in patients who were already using statins receiving anthracycline and trastuzumab in the context of breast cancer. The study was to be presented during the ACC 2020 scientific sessions together with the World Congress of Cardiology. However, it had to be called off<a href="https://solaci.org/en/2020/03/23/virtual-acc-2020-statins-could-also-protect-against-chemotherapy-cardiotoxicity/" title="Read more" >...</a>
During the 50th SOLACI Regional Sessions carried out in Manta, Ecuador, on March 6 thru 7, 2020, the traditional Young Cardiologists Case Contest took place, sponsored by ABBOTT VASCULAR. This contest is meant to motivate young interventionists to present their work before prestigious Latin American professionals and, this way, start building experience in the international arena. In<a href="https://solaci.org/en/2020/03/16/ecuador-2020-young-cardiologists-contest-winner/" title="Read more" >...</a>
We have the pleasure to announce the creation of SOLACI’s research department under the name “SOLACI Research”, aimed at fostering clinical research in the region by creating registries, developing local guidelines, core-lab, consultation and training sessions coordinated by SOLACI. All interventional cardiologists meeting our basic requirements willing to participate can join the research department as<a href="https://solaci.org/en/2020/03/05/solaci-research-solacis-innovative-research-area/" title="Read more" >...</a>
The American College of Cardiology (ACC) has launched a document summarizing the potential implications of the new coronavirus identified in Wuhan, China. This new virus has been called COVID-19 by the WHO. According to the WHO reports, there are around 93000 confirmed cases across the world, and around 12600 are outside China. In Latin America,<a href="https://solaci.org/en/2020/03/04/acc-recommendations-against-the-new-coronavirus/" title="Read more" >...</a>
As a “friendly,” easy-to-read document, the new European guidelines on pulmonary embolism (PE) include an excellent summary chart with new and modified items (compared with the 2014 guidelines), and also some sort of final conclusion composed of crucial tips and contraindications that come in handy in case of emergency. Diagnosis stage In suspected high-risk PE,<a href="https://solaci.org/en/2020/03/04/what-to-do-and-what-not-to-do-in-case-of-pe-according-to-the-new-european-guidelines/" title="Read more" >...</a>
Under much debate, the treatment of uncomplicated type B aortic dissection is still uncertain. Several studies with methodological limitations have shown that endovascular treatment plus optimal medical treatment might be beneficial, compared with medical treatment alone. This meta-analysis sought to define more clearly the treatment strategy in patients with acute and subacute uncomplicated type B<a href="https://solaci.org/en/2020/01/21/medical-vs-endovascular-treatment-in-uncomplicated-type-b-aortic-dissection/" title="Read more" >...</a>
1- Consensus on How to Conduct Follow-Up in Peripheral Vascular Disease Peripheral vascular disease involves multiple areas and, therefore, can have very different presentations (from complete lack of symptoms to disabling symptoms). Depending on clinical presentation, general condition, anatomical localization, and lesion extension, revascularization can be indicated alongside optimal medical treatment. Read also HERE 2-<a href="https://solaci.org/en/2020/01/06/the-most-read-articles-of-december-in-solaci-org/" title="Read more" >...</a>
In cases where it is difficult to demonstrate the improvement of a drug or a device in hard endpoints such as mortality, we should look for softer and easier to prove endpoints. The problem is that these soft endpoints are often subjective (such as sensation of shortness of breath or angina pectoris) and they could<a href="https://solaci.org/en/2019/12/08/percutaneous-annuloplasty-in-functional-mitral-regurgitation-vs-sham-procedure/" title="Read more" >...</a>
On Saturday December 14, 2019, the 17th Meeting of the Venezuelan Society of Interventional Cardiology (SOVECI) will be held at Caracas Clinics Hospital’s Auditorium. National and international specialists will be attending and will be addressing several topics of interest in the field of interventional cardiology. There will also be live and edited cases. For SOLACI it<a href="https://solaci.org/en/2019/12/05/the-17th-annual-meeting-of-the-venezuelan-society-of-interventional-cardiology-is-coming/" title="Read more" >...</a>